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Cardiac Toxicities of Antibiotics
by H. Richard Adams,* Janet L. Parker,* and
Lenard R. Durrett*
Isolated heart muscle preparations are useful in the study of cardiac toxicities of drugs and environ-
mental chemicals: such tissues allow assessment of chemical effects on heart muscle that is free from
indirect in vivo influences that can mask or even accentuate cardiac responses measured in the intact
aninal. In the present study, left atria ofguineapigs were used todemonstrate adirect cardiac depressant
effect ofgreater-than-therapeutic concentrations ofseveral aminoglycoside antibiotics. The toxic effect of
these antibiotics seems to be a calcium-dependent event, and may prove useful to characterize contractile
responses oftheheart. Otherantibiotic agentscan alsodepress cardiovascular function, assummarized in
this report, but mechanisms of action have not been clearly defined.
Introduction
A variety of pharmacologic and environmental
chemicals can influence cardiovascular function;
however, such effects are not always easily detect-
able before serious damage to the heart or blood
vessels has occurred. The heart is particularly sus-
ceptible to the actions ofexogenous chemicals due,
in no small part, to the functional dependence of
this organ ondynamic and discrete ionic balances at
the myocardial cell level (1). Not only can drugs
directly affect myocardial integrity, but they may
also modify cardiac performance by decreasing the
ability ofthe heart to compensate when affected by
disease. In recognition of such problems and the
resulting need forexperimental means ofidentifying
cardiovascular effects of chemicals, "model" car-
diac systems have been developed to characterize
normal heart function and to predict the respon-
siveness of this organ to chemical challenge. Al-
though limitations are routinely encountered when
effects of drugs in isolated tissue models are ex-
trapolated directly to human populations, heart
muscle preparations have generally proven to be
useful in the study of cardiac toxicities of chemi-
cals.
Recently, we became interested in cardiac muscle
and vascular smooth muscle models and have found
certain in vitro preparations to provide predictive
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information relative to in vivo cardiovascular man-
ifestations of drug toxicities (2-4). In addition, a
particular group of clinically used agents was iden-
tified to also have potential application for probing
cardiovascular function. These drugs, the amino-
glycoside antibiotics (i.e., neomycin-streptomycin
group), were found to depress arterial muscle func-
tion in rather specific manners that could best be
explained by an inhibitory effect on a portion of
cellular calcium ion (Ca2+) bound to superficial
membrane sites (2, 5, 6). Due to the contractile de-
pendence of heart muscle on adequate cellular
stores ofCa2+ (1, 7), it also seemed that the cardiac
depressant effects of these agents could involve
Ca2+. Studies with atrial muscle of rats supported
this contention (3) but provided little information
relative to the influence ofthese agents on the con-
tractile reactivity ofheart muscle to inotropic inter-
ventions. The present report describes preliminary
studies of the effects of selected aminoglycoside
antibiotics on contractile function of isolated heart
muscle of the guinea pig and also summarizes vari-
ous aspects of the general subject of cardiac tox-
icities of antibiotic agents.
Materials and Methods
Male albino guinea pigs weighing between 150
and 250 g were decapitated with a guillotine; the
hearts were rapidly excised and immediately placed
in a Krebs-bicarbonate buffered solution (compo-
October 1978 217sition given below) aerated with 95% 02-5% Co2.
The tension developed by atria was recorded in a
similar way to that previously reported (8). The left
atrial appendage was carefully dissected from the
heart, mounted between two miniature clamps and
suspended vertically in a 15 ml tissue bath. The
upper clamp was connected by silk suture to a pre-
calibrated force-displacement transducer (Grass Ft
.03) for measuring isometric contractions on a mul-
tichannel recorder (Grass model 7B). The lower
clamp was connected directly to a stationary rod in
the bottom of the tissue bath. Muscle length was
adjusted by raising or lowering the force-
displacement transducer mounting unit with an in-
tegral micromanipulator. Initially, length-tension
relationships were tested with each muscle and 1 g
of diastolic tension was found consistently to yield
maximum or near maximum contractile tension.
Thereafter, 1 g of diastolic tension was placed on
each muscle. The maximum rate of tension de-
velopment (dTldt), a more sensitive inotropic index
than tension alone, was measured in some prepara-
tions by electrically differentiating contractile ten-
sion by use of a Grass 7P20 differentiator.
Electrical stimulation was accomplished with
single square wave impulses of greater-than-
threshold voltage and 2 msec pulse duration, de-
livered at designated frequencies (1.0 Hz unless
stated otherwise) from a Grass S44 stimulator.
Contractile tension anddTIdt were measured and
expressed as grams ofdeveloped tension (or force)
and grams per second, respectively, or values ob-
tained in the presence ofa drug were expressed as a
percentage of predrug (control) values obtained in
that muscle. All measurements are expressed as the
mean + 1 standard error ofthe mean (X + SE) and
the difference between two means was evaluated
statistically by Student's t test.
The Krebs-bicarbonate solution was identical
with that employed previously in heart muscle
studies (8) and contained (millimolar concentra-
tion): NaCl, 118; KCl, 4.7; NaHCO3, 24; KH2PO4,
1.2; MgSO4, 1.2; CaCl2, 2.5; and glucose 11. Ethyl-
enediaminetetraacetic acid (EDTA, 3.3 x 10-5M)
was added to prevent oxidation of catecholamines.
Solutions were prepared with demineralized water,
adjusted to pH 7.4, continuously aerated with 95%
02-5% CO2 and maintained at 34 + 0.5°C.
The drugs used were 1-isoproterenol hy-
drochloride (Sigma Chemical Company, St. Louis,
Mo.), digoxin (The Vitarine Co., Inc., New York)
and the sulfate salts ofgentamicin (Schering Corp.,
New Jersey), kanamycin (Sigma), amikacin
(BB-K8; Bristol Laboratories, New York) and
sisomicin (Schering). All concentrations refer to the
base. Effects ofdrugs on heart muscle were exam-
ined by additions of small aliquots of concentrated
stock solutions directly to the bathing medium of
the tissue bath. After a drug response was obtained
forthe designated time interval, the bathing solution
was changed several times and replaced with fresh
medium. If the muscle was to be reexamined for
paired responses, time was allowed for contraction
to return to control values and to stabilize before
proceeding with an experiment. With all prepara-
tions, the muscle was allowed to stabilize for at
least 45 min after contraction had been initiated
before an experiment was started, and bathing so-
lution was routinely replaced every 15-20 min.
Results
Initial studies evaluated the effects ofgentamicin
(2.0, 4.0mM) on contractile responses to Ca2+.
Cumulative concentration-response curves to Ca2+
(2.5-14.0mM) were first determined in atria not
treated with gentamicin and then (after appropriate
rinsings and restabilization) redetermined after the
negative inotropic effects of gentamicin reached a
steady-state value (about 15 min). As shown in Fig-
ure 1, 2 and 4mM gentamicin reduced contractile
force (tension) by about 60 and 90%o, respectively,
in the control medium containing 2.5mM Ca2 .
However, despite the pronounced depressant ef-
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FIGURE 1. Effects ofgentamicin (Gent) on the positive inotropic
response to Ca2+ inelectrically drivenleftatriaofguineapigs:
(0) prior to exposure to Gent; (0), 10 min after exposure to
2mM Gent; (O) 10 min after exposure to 5mM Gent; (5)
after recovery from Gent. Each point represents the mean +
S.E. of6 atria. Contractile force is expressed as a percentage
ofpredrug control values. Values in initial 2.5mM Ca2+ repre-
sent contractile values prior to addition of Gent; values in
second 2.5mM Ca2+ indicate contractile tension observed
after 10 min exposure to the designated concentration of
Gent.
Environmental Health Perspectivesfects of gentamicin, the antibiotic-treated heart
muscle preparations responded to the positive ino-
tropic effects ofCA2+. In fact, when the larger con-
centrations of Ca2+ (> 8mM) were tested, the con-
tractile responses of gentamicin-treated atria were
similar to control Ca2+ responses (Fig. 1). Thus, the
cardiac depressant activities of even large concen-
trations of gentamicin could be overcome by in-
creasing Ca2+ availability.
If the Ca2+-gentamicin interaction represented a
simple physiologic antagonism, then positive ino-
tropic agents other than Ca2+ should also be ex-
pected to overcome the depressant action of the
antibiotic. This possibility was examined by com-
paring the contractile effects of different interven-
tions (i.e., isoproterenol, digoxin and increased fre-
quency of stimulation) in control atria and in atria
treated with large concentrations of gentamicin.
Responses to cumulative increases in the con-
centration ofisoproterenol (1 x 10-10 to 3 x 10-7M)
were determined in eight control atria and in eight
other atria treated either with 2mM (n = 4) or 4mM
(n = 4) gentamicin. As shown in Figure 2, isopro-
terenol produced a characteristic increase in
contractile tension and dT/dt in both control and
gentamicin-treated tissues. However, contractile
responses to isoproterenol were reduced in
gentamicin-treated atria, and even large amounts of
isoproterenol (> 1 x 10-8M) could not increase
contractility ofgentamicin-treated atria to the mag-
nitude seen in control atria (Fig. 2).
Contractile responses to digoxin (1 to 4 ,tM) in
controlatria(n = 12) andin atriaexposed to 1 (n = 5),
2 (n=4), or 4mM (n=3) gentamicin are summarized
in Figure 3. Although gentamicin-treated muscles
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FIGURE 2. Effects of gentamicin (G) on the positive inotropic
response to isoproterenol in guinea pig left atria: (0) control
(n = 8)atria; (0)atriatreated with2.0mMgentamicin (n = 4);
(U) atria treated with 4.0mM gentamicin (n = 4). Contractile
tension (CT) and dTldt are shown as percent of pre-
isoproterenol control values. Each point represents the mean
± S. E.
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FIGURE 3. Effects ofgentamicin (Gent) onthe inotropic effects of
digoxin: (0) atria not treated with Gent (n = 12); (0)
atria treated with 1.OmM (n = 5) (U) 2.0mM (n = 4), or (A)
4.0mM (n = 3) Gent. Values shown at the first 0.0 concentra-
tionofdigoxin represent contractile force priorto exposure to
either drug. Values at the second 0.0 digoxin concentration
represent contractile force 10 min after the addition ofdesig-
nated Gent concentrations. All values are expressed as per-
cent of predrug control. Each point represents the mean
± S.E.
demonstrated inotropic responsiveness to digoxin,
contractile force of these tissues did not reach the
level observed in control atria (Fig. 3). Data in Fig-
ure 3 also demonstrate thatthe effects ofgentamicin
in control atria (i.e., not exposed to any drug) are
concentration-dependent since 1, 2, and 4mM re-
duced contractile strength by about 35, 55, and
80%, respectively, prior to exposure to digoxin.
Similar concentration-dependent effects of gen-
tamicin were observed over a wide range of con-
centrations (0.1-4mM) of the antibiotic (data not
shown).
Frequency-tension relationships were determined
in atria before treatment with gentamicin and again
after the negative inotropic effect of gentamicin
reached steady state. As shown in Figure 4 with
typical myograms and as summarized in Figure 5,
contractility ofgentamicin-treated atriaincreased as
stimulation frequency was increased from 0.1 to 2.0
Hz. However, contractile tension and dTldt re-
sponses of these atria did not reach the values ob-
tained by control atria (Figs. 4 and 5). The reversi-
bility of the gentamicin effect is also demonstrated
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in Figures 4 and 5, since responses ofthe atria after
gentamicin was removed from the tissue bath (re-
covery data) were similar to control dataobtained in
the pre-gentamicin period.
Although present studies utilized gentamicin as a
representative aminoglycoside agent, several test
experiments were conducted with sisomicin,
amikacin and kanamycin. As was seen with gen-
tamicin, large concentrations (> 2mM) of these
l~ ^ agents were required to appreciably reduce con-
tractile force. Absolute values ofcontractile tension
ofatria exposed to a selected concentration ofeach
1'0 15 2.0 25 of these antibiotics are summarized in Table 1.
FIGURE 4. Left atrial myograms showing the response of con-
tractile tension (CT) to frequency variation: (A) in control;
(B) after treatment with 2.0mM gentamicin; (C) followed by
recovery after removal of the drug. Tracings are typical of
those summarized in Fig. 5.
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FIGURE 5. Effects of gentamicin (Gent) on the frequency-force
relationship. Absolute values of contractile tension (g) and
+dTldt (g/sec) are shown at different frequencies in atria (0)
prior to exposure to Gent, (d) following exposure to Gent for
10 min, and (0) after recovery from Gent. Each point repre-
sents the mean + S.E. from 6 atria.
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Discussion
Metabolic byproducts of various microorganisms
have been utilized for different biomedical pur-
poses, in addition to their most useful application as
antibacterial drugs. In this respect, antibiotics could
be considered as fortuitous and natural "contami-
nants" of the environment. The aminoglycoside
group of antibiotics, for example, have greatly en-
hanced the treatment of a wide range of infections
caused by gram-negative organisms. Although the
bactericidal effects of these drugs differ as to
specific spectrum of activity, these agents produce
similar adverse side effects, including toxicities of
the auditory-vestibular apparatus and the kidney
(9), neuromuscular blockade (10) and, in some inci-
dences, cardiovascular depression (Table 2). In the
present study, cardiotoxicity of selected amino-
glycoside antibiotics was demonstrated and fur-
thermore, evaluated to include potential inter-
relationships with other inotropic interventions.
Large concentrations of gentamicin, kanamycin,
amikacin, and sisomicin reduced isometric contrac-
tile tension of electrically driven left atria ofguinea
pigs. This tissue preparation has the advantage of
allowing assessment ofdrug effects on heart muscle
that is free from indirect in vivo influences which
can mask or even accentuate cardiac responses
measured in the whole animal. Using gentamicin as
a representative agent, we found that this drug not
only produced a negative inotropic effect in isolated
heart muscle, but also decreased contractile re-
sponses to several positive inotropic interventions,
i.e., isoproterenol, Ca2+, digoxin, and increased
frequency of stimulation. However, gentamicin in-
teracted with Ca2+ responses differently than it af-
fected responses to the other agents. Depression of
cardiac function by gentamicin could be completely
antagonized by increased concentrations of Ca2+,
but only partially by the positive contractile effects
ofincreased stimulation frequency or supramaximal
concentrations of isoproterenol or digoxin. This
difference suggests that the cardiac depressant ef-
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iTable 1. Myocardial depressant effect of antibiotics in isolated electrically-driven left atria of guinea pigs.
Contractile tension, g + SE
Antibiotic n valuea Control Responseb % of Control Significancec
Kanamycin 10 2.19 ± 0.12 1.54 ± 0.13 70.1 ± 4.9 p < 0.01
(3.8mM)
Amikacin 1.99 ± 0.19 1.33 ± 0.15 66.8 ± 3.4 p < 0.001
(4mM) 6
Sisomicin 9 1.92 ± 0.25 1.13 ± 0.19 56.3 + 4.5 p < 0.001
(2mM)
a n value = number of atria.
b Response measured after 10 min exposure to antibiotic.
c Paired t-test.
Table 2. Cardiovascular effects of antibiotics.
Antibiotic Species Preparation Effect Comments Reference
Streptomycin Dog In vivo Cardiovascular During (17)
depression anesthesia
Dihydrostreptomycin
Kanamycin
Neomycin
Gentamicin
Tetracyclines
Chloramphenicol
Cat, rabbit
Dog
Dog, cat
rhesus monkey
Rat
Human
Rabbit
Dog
Human
Rabbit
Dog
Rat
Human
Rhesus monkey,
baboons
Rat
Rhesus monkey
Dog
Dog
Cat, rabbit
Rabbit, cat
In vitro
(Langendorf)
In vitro
(heart-lung)
In vivo
In vitro
(papillary muscle)
In vitro
(Langendorf)
In vitro
(heart-lung)
In vitro
(Langendorf)
In vivo
In vitro
(papillary muscle)
In vivo
In vitro
(atria)
In vivo
In vitro
(heart-lung)
In vivo
In vitro
(Langendort)
In vitro
(Langendort)
--Jr, _I
Contractile
depression
Cardiovascular
depression
Hypotension
Contractile
depression
Persistent
Hypotension
Contractile
depression
Contractile
depression
Cardiac arrest
Contractile
depression
Cardiovascular
depression
Contractile
depression
Cardiovascular
depression
Cardiovascular
depression
Contractile
depression
Cardiovascular
depression
Contractile
depression
Cardiovascular
depression
Contractile
depression
Contractile
depression
Additive w/
halothane
Postoperative
cardiac surgery
Overdose
During
anesthesia
Additive w/
halothane
Review of
case reports
During
anesthesia
During
anesthesia
During
anesthesia
October 1978
(17, 18)
(16)
(21, 25)
(24)
(17)
(18)
(16)
(26)
(27)
(17)
(24)
(10)
(4, 21)
(3)
(4)
(16)
(17)
(17, 18)
(17, 18)
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Antibiotic Species Preparation Effect Comments Reference
Dog In vivo Cardiovascular During (17)
depression anesthesia
Dog In vitro Contractile (16)
(heart-lung) depression
Toad In vitro Contractile (22)
depression
Chick In vitro Decreased Embryonic (23)
pulsatile rate chick heart
Rat In vitro Contractile Additive w/ (24)
(papillary muscle) depression halothane
Erythromycin Cat In vitro Contractile (17)
(Langendorf) depression
Dog In vivo Cardiovascular During (17, 19)
depression anesthesia
Dog In vivo Ventricular After digitalis (20)
arrhythmias or ischemia
Lincomycin Human Cardiac arrest Overdose (15)
Oleandomycin Rabbit In vitro Contractile (18)
(Langendorf) depression
Dog In vivo Cardiovascular During (19)
depression anesthesia
Colymicin Dog In vivo Cardiovascular During (17)
depression anesthesia
Cat In vitro Contractile (17)
(Langendorf) depression
fect of aminoglycosides is a Ca2+-dependent
phenomenon that can be antagonized by increased
concentrations of Ca2+ in the interstitium, but only
partially antagonized by procedures that mobilize
available Ca2+ (e.g., isoproterenol, digoxin, and in-
creased frequency of stimulation) (1, 7).
The dependence of myocardial contraction on an
increase in the intracellular concentration of free
Ca2+ is now unequivocal, and an influx ofCa2+ into
the myofiber directly activates actin-myosin ele-
ments and/or causes additional release ofCa2+ from
cellular sequestration sites (1, 7). The precise
molecular mechanisms and cellular loci involved in
myocardial Ca2+ fluxes have not been precisely
identified and are under intensive investigation in
many laboratories. In view of the effects of gen-
tamicin on myocardial contractile function, this
antibiotic may prove useful as apharmacologic tool
to probe Ca2+-dependent inotropic events in heart
muscle. The antagonistic interaction of amino-
glycosides and Ca2+ has been recognized in a variety
of mammalian tissues (5, 6, 12-14), and present
findings provide a basis for more detailed investiga-
tion of the influence of these agents on Ca2+-
dependent processes in contracting myocardium.
Although the present study focused on the
aminoglycosides, the potential cardiovascular tox-
icities of other antibiotics should not be disre-
garded. For example, large doses of lincomycin
have been reported to disrupt impulse conductance
through the excitable tissues ofthe myocardium, re-
sulting in arrhythmias, cardiac standstill and, in
some cases, ventricular fibrillation (15). Also it
seems that the arrhythmogenic effects of digitalis
can be affected by lincomycin (15). Hypotensive
episodes have occurred during administration of
chloramphenicol, and studies with perfused heart
preparations revealed a myocardial depressant ef-
fect ofthis antibiotic (16). Studies with anesthetized
dogs showed that tetracycline, vancomycin, ery-
thromycin, and colymycin decreased cardiac output,
systemic blood pressure and myocardial contractile
force (17). Tetracyclines, erythromycin, olean-
domycin, chloramphenicol, and colymycin have all
been reported to decrease contractile force of iso-
lated cardiac preparations (16-18). Table 2 sum-
marizes several reports describing in vivo and in
vitro cardiovascular effects of various antibiotics,
including the aminoglycosides. Since many ofthese
reports involve experimental studies with greater-
than-therapeutic doses of the antibiotics, these
agents should notbe indiscriminately categorized as
Environmental Health Perspectives 222"cardiovascular depressants." Nevertheless, in
view ofthe now rather lengthy list ofantibiotics that
have been reported to affect hemodynamics, the
potential for cardiovascular toxicity with these
agents should be considered when untoward cir-
culatory changes are detected in patients undergo-
ing antibacterial therapy.
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